Internal Reference Number: FOI_9139
Date Request Received: 07/01/2026 00:00:00
Date Request Replied To: 21/01/2026 00:00:00
This response was sent via: By Email
Request Summary: clinical trial participation rates for blood cancer
Request Category: Students (Educational)
| Question Number 1: Under the Freedom of Information Act of 2000, I would like to request the following information for your healthcare trust during the period 1st Jan2015 to 31st December 2025: Format: please provide data in a machine-readable format (e.g. excel or CSV) and return to me via email. I am requesting aggregated counts and non-identifiable data only. Please withhold any information that would potentially identify individual patients and instead provide aggregated counts (by year, diagnosis category, and demographic bands) Annual number of patients diagnosed with blood cancers per year overall, and by subtype: 鈥� Lymphomas (C81-86) 鈥� Malignant immunoproliferative diseases (C88) 鈥� Multiple myeloma and malignant plasma cell neoplasms (C90) 鈥� Leukaemia (C91-C95) 鈥� Unspecified malignant neoplasms of lymphoid, haematopoietic and related tissues (C96) | |
| Answer To Question 1: Please see our response in the Excel spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  13434 - FOI_9139 - Clinical trial participation rates for blood cancer.xlsx | |
| Question Number 2: The number of blood cancer clinical trials available, including active trials that are recruiting and trials that are not actively recruiting. | |
| Answer To Question 2: 13 blood cancer clinical trials are available, including active trials that are recruiting and trials that are not actively recruiting but are in follow up. | |
| Question Number 3: Annual number of patients who were enrolled in interventional or observational clinical trials related to these blood cancers per year. | |
| Answer To Question 3: Annual number of patients who were enrolled in interventional or observational clinical trials related to these blood cancers is on average 4 | |
| Question Number 4: The scientific title, clinical trial registration number, phase (I/II/III/IV/other), opening and closing recruitment dates, number recruited at this trust, and location of each trial related to blood cancer. | |
| Answer To Question 4: See spreadsheet attached To accompany this answer to question 4 please also see the documents listed below: FOI_9139 20 Jan 2026.xlsx | |
| Question Number 5: The current number of dedicated research staff (e.g. research nurses, research practitioners, study coordinators etc.) assigned to haematological clinical trials. | |
| Answer To Question 5: Equivalent of 2 dedicated staff are assigned to haematological clinical trials | |
| Question Number 6: If available, annual counts of invitations/offers made to eligible patients to consider trial participation. | |
| Answer To Question 6: Average of 4 invitations annually | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 月色直播 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
